Injectable viles.

Dr. Reddy's launches generic Invanz

The Invanz brand and generic had a market value of $205 million for the 12 months ended March 2021, according to IQVIA.
Levy

Dr. Reddy’s is introducing ertapenem for injection, 1 g/vial.

The product is the generic of Merck's Invanz.

The Invanz brand and generic had a market value of $205 million for the 12 months ended March 2021, according to IQVIA.

Dr. Reddy’s product is available in packs of 10 vials per carton.

X
This ad will auto-close in 10 seconds